Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Achenbach, T. M. (1991). Integrative guide for the 1991 CBCL 14–18, YSR, and TRF profiles. Burlington, VT: University of Vermont Department of Psychiatry.
Adriani, W., Spijker, S., Deroche-Gamonet, V., Laviola, G., Le Moal, M., Smit, A. B., et al (2003). Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats. Journal of Neuroscience, 23(11), 4712–4716.
Aizenstein, M. L., Segal, D. S., & Kuczenski, R. (1990). Repeated amphetamine and fencamfamine: Sensitization and reciprocal cross-sensitization. Neuropsychopharmacology, 3, 283–290.
Andersen, S. L., & Navalta, C. P. (2004). Altering the course of neurodevelopment: A framework for understanding the enduring effects of psychotropic drugs. International Journal of Developmental Neuroscience, 22, 423–440.
Anthony, J. C., Warner, L. A., & Kessler, R. C. (1994). Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology, 2, 244–268.
Arbeit, M. L., Nicklas, T. A., Frank, G. C., Webber, L. S., Miner, M. H., & Berenson, G. S. (1988). Caffeine intakes of children from a biracial population: The Bogalusa heart study. Journal of the American Dietetic Association, 88(4), 466–471.
Arria, A. M., Caldeira, K. M., O’Grady, K. E., Vincent, K. B., Johnson, E. P., & Wish, E. D. (2008). Nonmedical use of prescription stimulants among college students: Associations with attention-deficit-hyperactivity disorder and polydrug use. Pharmacotherapy, 28(2), 156–169.
Bada, H. S., Das, A., Bauer, C. R., Shankaran, S., Lester, B., Wright, L. L., et al (2002). Gestational cocaine exposure and intrauterine growth: Maternal lifestyle study. Obstetrics and Gynecology, 100(5 Pt. 1), 916–924.
Barkley, R. A. (1991). The ecological validity of laboratory and analogue assessment methods of ADHD symptoms. Journal of Abnormal Child Psychology, 19(2), 149–178.
Barone, J. J., & Roberts, H. R. (1996). Caffeine consumption. Food and Chemical Toxicology, 34(1), 119–129.
Bech, B. H., Nohr, E. A., Vaeth, M., Henriksen, T. B., & Olsen, J. (2005). Coffee and fetal death: A cohort study with prospective data. American Journal of Epidemiology, 162(10), 983–990.
Benowitz, N. L. (1990). Clinical pharmacology of caffeine. Annual Review of Medicine, 41, 277–288.
Berkowitz, R. L., Coustan, D. R., & Mochizuki, T. K. (1998). Handbook for prescribing medication during pregnancy. Philadelphia, PA: Lippincott-Raven.
Bernstein, G. A., Carroll, M. E., Dean, N. W., Crosby, R. D., Perwien, A. R., & Benowitz, N. L. (1998). Caffeine withdrawal in normal school-age children. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 858–865.
Bertrand, J., Floyd, R. L., Weber, M. K., O’Connor, M. J., Riley, E., Johnson, K. A.et al, . (2004). National Task Force on fetal alcohol syndrome/fetal alcohol effects. Fetal alcohol syndrome: Guidelines for referral and diagnosis. Screening and brief intervention. Atlanta, GA: Centers for Disease Control and Prevention.
Biederman, J., Wilens, T., Mick, E., Faraone, S. V., Weber, W., Curtis, S.et al, . (1997). Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. Journal of the American Academy Child Adolescent Psychiatry, 36(1), 21–29.
Biederman, J., Wilens, T., Mick, E., Spencer, T., & Faraone, S. V. (1999). Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics, 104(2), e20.
Bradley, C. (1937). The behavior of children receiving benzedrine. American Journal of Psychiatry, 94, 577–585.
Brandon, C. L., Marinelli, M., Baker, L. K., & White, F. J. (2001). Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology, 25, 651–661.
Brazier, J. L. & Salle, B. (1981). Conversion of theophylline to caffeine by the human fetus. Seminars in Perinatology, 5, 315–320.
Brazier, J. L., Ritter, J., Berland, M., Khenfer, D., & Faucon, G. (1983). Pharmacokinetics of caffeine during and after pregnancy. Developmental Pharmacology and Therapeutics, 6(5), 315–322.
Briggs, G. G., Freeman, R. K., & Yaffe, S. J. (1998). Drugs in pregnancy and lactation. 4th ed. Baltimore, MD: Wilkins & Wilkins.
Brown, S. A., & Tapert, S. F. (2004). Adolescence and the trajectory of alcohol use: Basic to clinical studies. Annals of the New York Academy of Sciences, 1021, 234–244.
Cargiulo, T. (2007). Understanding the health impact of alcohol dependence. American Journal of Health-System Pharmacy, 64(5 Suppl. 3), S5–S11.
Castellanos, F. X., & Rapoport, J. L. (2002). Effects of caffeine on development and behavior in infancy and childhood: A review of the published literature. Food and Chemical Toxicology, 40(9), 1235–1242.
Caster, J. M., Walker, Q. D., & Kuhn, C. M. (2007). A single high dose of cocaine induces differential sensitization to specific behaviors across adolescence. Psychopharmacology, (Berl), 193(2), 247–260.
Centers for Disease Control and Prevention (CDCP). (1997). Perspectives in disease prevention and health promotion, smoking-attributable mortality and years of potential life lost-United States, 1984. (Morbidity and mortality weekly report [serial online] 46, 441–451). Retrieved January 15, 2008, from http://www.cdc.gov/mmwr/preview/mmwrhtml/00047690.htm.
Centers for Disease Control & Prevention (CDCP). (2002). PRAMS Surveillance Report. Retrieved December 11, 2007, from http://www.cdc.gov/prams/2002PRAMSSurvReport/.
Centers for Disease Control and Prevention (CDCP). (2004). Frequently asked questions: Fetal alcohol syndrome. Retrieved December 11, 2007, from http://www.cdc.gov/NCBDDD/fas/faqs.htm.
Centers for Disease Control and Prevention (CDCP). (2005). Annual smoking-attirbutable mortality, years of potential life lost, and productivity losses – United States, 1997–2001. (Morbidity and mortality weekly report [serial online] 54(25), 625–628). Retrieved December 11, 2007, from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5425a1.htm.
Chaloupka, F. J., & Johnston, L. D. (2007). Bridging the gap: Research informing practice and policy for healthy youth behavior. American Journal of Preventive Medicine, 33(Suppl. 4), S147–S161.
Chambers, R. A., Taylor, J. R., & Potenza, M. N. (2003). Developmental neurocircuitry of motivation in adolescence: A critical period of addiction vulnerability. American Journal of Psychiatry, 160(6), 1041–1052.
Charatan, F. (2006). FDA committee votes for warning labels on stimulant drugs. British Medical Journal, 332(7538), 380.
Charness, M. E., Hu, G., Edwards, R. H., & Querimit, L. A. (1993). Ethanol increases delta-opioid receptor gene expression in neuronal cell lines. Molecular Pharmacology, 44(6), 1119–1127.
Chase, T. D., Carrey, N., Brown, R. E., & Wilkinson, M. (2005a). Methylphenidate regulates c-fos and fosB expression in multiple regions of the immature rat brain. Brain Research, Developmental Brain Research, 156(1), 1–12.
Chase, T. D., Carrey, N., Brown, R. E., & Wilkinson, M. (2005b). Methylphenidate differentially regulates c-fos and fosB expression in the developing rat striatum. Brain Research, Developmental Brain Research, 157(2), 181–191.
Chase, T., Carrey, N., Soo, E., & Wilkinson, M. (2007). Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum. Neuroscience, 144(3), 969–984.
Colby, S. M., Tiffany, S. T., Shiffman, S., & Niaura, R. S. (2000). Are adolescent smokers dependent on nicotine? A review of the evidence. Drug and Alcohol Dependence, 59(Suppl. 1), S83–S95.
Conners, C. K., Sitarenios, G., Parker, J. D., & Epstein, J. N. (1998). The revised Conners’ parent rating scale (CPRS-R): Factor structure, reliability, and criterion validity. Journal of Abnormal Child Psychology, 26(4), 257–268.
Cornelius, M. D., Leech, S. L., Goldschmidt, L., & Day, N. L. (2000). Prenatal tobacco exposure: Is it a risk factor for early tobacco experimentation? Nicotine and Tobacco Research, 2(1), 45–52.
Crews, F., He, J., & Hodge, C. (2007). Adolescent cortical development: A critical period of vulnerability for addiction. Pharmacology Biochemistry and Behavior, 86(2), 189–199.
Crews, F. T., Mdzinarishvili, A., Kim, D., He, J., & Nixon, R. (2006). Neurogenesis in adolescent brain is potently inhibited by ethanol. Neuroscience, 137(2), 437–445.
Daly, J. W., & Fredholm, B. B. (1998). Caffeine – An atypical drug of dependence. Drug and Alcohol Dependence, 51(1–2), 199–206.
Day, N. L., Richardson, G. A., Goldschmidt, L., & Cornelius, M. D. (2000). Effects of prenatal tobacco exposure on preschoolers’ behavior. Journal of Developmental and Behavioral Pediatrics, 21(3), 180–188.
DeBellis, M. D., Clark, D. B., Beers, S. R., Soloff, P. H., Boring, A. M., Hall, J.et al, . (2000). Hippocampal volume in adolescent-onset alcohol use disorders. American Journal of Psychiatry, 158(5), 820–821.
DeBellis, M. D., Narasimhan, A., Thatcher, D. L., Keshaven, M. S., Soloff, P., & Clark, D. B. (2005). Prefrontal cortex, thalamus, and cerebellar volumes in adolescents and young adults with adolescent-onset alcohol use disorders and comorbid mental disorders. Alcoholism, Clinical and Experimental Research, 29(9), 1590–1600.
Deitrich, R. A., Dunwiddie, T. V., Harris, R. A., & Erwin, V. G. (1989). Mechanism of action of ethanol: Initial central nervous system actions. Pharmacological Reviews, 41, 489–537.
DiFranza, J. R., Savageau, J. A., Fletcher, K., O’Loughlin, J., Pbert, L., Ockene, J.et al, . (2007). Symptoms of tobacco dependence after brief intermittent use: The development and assessment of nicotine dependence in youth-2 study. Archives of Pediatric and Adolescent Medicine, 161, 704–710.
Dumas, M., Gouyon, J. B., Tenenbaum, D., Michiels, Y., Escousse, A., & Alison, M. (1982). Systematic determination of caffeine plasma concentrations at birth in preterm and full term infants. Developmental Pharmacology and Therapeutics, 4(Suppl.), 182–186.
Efron, D., Jarman, F. C., & Barker, M. J. (1998). Child and parent perceptions of stimulant medication treatment in attention deficit hyperactivity disorder. Journal of Paediatrics and Child Health, 34(3), 288–292.
Elkins, R., Rapoport, J. L., Zahn, T. P., Buchsbaum, M. S., Weingartner, H., Kopin, I. J.et al, . (1981). Acute effects of caffeine in normal prepubertal boys. American Journal of Psychiatry, 138, 178–183.
Eskenazi, B. & Castorina, R. (1999). Association of prenatal maternal or postnatal environmental tobacco smoke exposure and neurodevelopmental and behavioral problems in children. Environmental Health Perspectives, 107, 991–1000.
Faden, V.B., & Graubard, B.I. (2000). Maternal substance use during pregnancy and developmental outcome at age three. Journal of Substance Abuse, 12(4), 329–340.
Faraday, M. M., Elliott, B. M., Phillips, J. M., & Grunberg, N. E. (2003). Adolescent and adult male rats differ in sensitivity to nicotine’s activity effects. Pharmacology, Biochemistry, and Behavior, 74(4), 917–931.
Feldman, R. S., Meyer, J. S., & Quenzer, L. F. (1997). Principles of neuropsychopharmacology. Sutherland, MA: Sinauer Associates, Inc.
Fergusson, D. M., Lynskey, M. T., & Horwood, L. J. (1994). Childhood exposure to alcohol and adolescent drinking patterns. Addiction, 89(8), 1007–1016.
Ferre, S., Fuxe, K., von Euler, G., Johansson, B., & Fredholm, B. B. (1992). Adenosine-dopamine interactions in the brain. Neuroscience, 51(3), 501–512.
Ferre, S., von Euler, G., Johansson, B., Fredholm, B. B., & Fuxe, K. (1991). Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proceedings of the National Academy of Sciences of the United States of America, 88(16), 7238–7241.
Frary, C. D., Johnson, R. K., & Wang, M. Q. (2005). Food sources and intakes of caffeine in the diets of persons in the United States. Journal of the American Dietetic Association, 105(1), 110–113.
Fredericks, E. M., & Kollins, S. H. (2004). Assessing methylphenidate preference in ADHD patients using a choice procedure. Psychopharmacology, 175, 391–398.
Fredericks, E. M., & Kollins, S. H. (2005). A pilot study of methylphenidate preference assessment in children diagnosed with ADHD. Journal of Child and Adolescent Psychopharmacology, 15(5), 729–741.
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999). Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacological Reviews, 51(1), 83–133.
Fried, P. A., & Watkinson, B. (1990). 36- and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol. Journal of Developmental and Behavioral Pediatrics, 11(2), 49–58.
Fried, P. A., & Watkinson, B. (2001). Differential effects on facets of attention in adolescents prenatally exposed to cigarettes and marijuana. Neurotoxicology and Teratology, 23(5), 421–430.
Galvan, A., Hare, T. A., Parra, C. E., Penn, J., Voss, H., Glover, G.et al, . (2006). Earlier development of the accumbens relative to orbitofrontal cortex might underlie risk-taking behavior in adolescents. Journal of Neuroscience, 26(25), 6885–6892.
Garland, M. (1998). Pharmacology of drug transfer across the placenta: Substance use in pregnancy. Obstetrics and Gynecology Clinics of North America, 25(1), 21.
Garrett, B. E., & Griffiths, R. R. (1996). The role of dopamine in the behavioral effects of caffeine in animals and humans. Pharmacology, Biochemistry and Behavior, 57(3), 533–541.
Gaytan, O., Yang, P., Swann, A., & Dafny, N. (2000). Diurnal differences in sensitization to methylphenidate. Brain Research, 846, 24–39.
George, L., Granath, F., Johansson, A. L., Olander, B., & Cnattingius, S. (2006). Risks of repeated miscarriage. Paediatric and Perinatal Epidemiology, 20(2), 119–126.
Giannelli, M., Doyle, P., Roman, E., Pelerin, M., & Hermon, C. (2003). The effect of caffeine consumption and nausea on the risk of miscarriage. Paediatric and Perinatal Epidemiology, 17(4), 316–323.
Ginzel, K. H., Maritz, G. S., Marks, D. F., Neuberger, M., Pauly, J. R., Polito, J. R.et al, . (2007). Critical review: Nicotine for the fetus, the infant and the adolescent? Journal of Health Psychology, 12(2), 215–224.
Glantz, M. D., & Chambers, J. C. (2006). Prenatal drug exposure effects on subsequent vulnerability to drug abuse. Development & Psychopathology, 18(3), 893–922.
Goodman, L. S., Hardman, J. G., Limbird, L. E., & Gilman, A. G. (2001). Goodman & Gilman’s the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill.
Grant, B. F., & Dawson, D. F. (1997). Age of onset and alcohol use and its association with DSM-IV alcohol abuse and dependence: Results of the National Longitudinal Alcohol Epidemiological Survey. Journal of Substance Abuse, 9, 103–110.
Grobin, A. C., Matthews, D. B., Devaud, L. L., & Morrow, A. L. (1998). The role of GABAA receptors in the acute and chronic effects of ethanol. Psychopharmacology, 139, 2–19.
Grund, T., Teuchert-Noodt, G., Busche, A., Neddens, J., Brummelte, S., Moll, G. H.et al, . (2007). Administration of oral methylphenidate during adolescence prevents suppressive development of dopamine projections into prefrontal cortex and amygdala after an early pharmacological challenge in gerbils. Brain Research, 1176, 124–132.
Guerriero, R. M., Hayes, M. M., Dhaliwal, S. K., Ren, J. Q., & Kosofsky, B. E. (2006). Preadolescent methylphenidate versus cocaine treatment differ in the expression of cocaine-induced locomotor sensitization during adolescence and adulthood. Biological Psychiatry, 60, 1171–1180.
Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W., & Goodman, A. G. (Eds.). (1996). Goodman & Gilaman’s the pharmacological basis of therapeutics. New York: McGraw Hill.
Hawken, C. M., Brown, R. E., Carrey, N., & Wilkinson, M. (2004). Long-term methylphenidate treatment down-regulates c-fos in the striatum of male CD-1 mice. Neuroreport, 15(6), 1045–1048.
Hellstrom-Lindahl, E., Seiger, A., Kjaeldgaard, A., & Nordberg, A. (2001). Nicotine-induced alterations in the expression of receptors in primary culture from human prenatal brain. Neuroscience, 105(3), 527–534.
Henningfield, J. E., & Griffiths, R. R. (1981). Cigarette smoking and subjective response: Effects of d-amphetamine. Clinical Pharmacology and Therapeutics, 30, 497–505.
Henningfield, J. E., Johnson, R. E., Jasinski, D. R., & Bozarth, M. A. (1987). Clinical procedures for the assessment of abuse potential (pp. 573–590). Berlin: Springer-Verlag.
Hughes, J. R., & Hale, K. L. (1998). Behavioral effects of caffeine and other methylxanthines on children. Experimental and Clinical Psychopharmacology, 6, 87–95.
Hughes, J. R., & Oliveto, A. H. (1997). A systematic survey of caffeine intake in Vermont. Experimental and Clinical Psychopharmacology, 5(4), 393–398.
James, J. E. (1991). Caffeine and Health. San Diego, CA: Academic Press, Ltd.
Jasinski, D. R., Johnson, R. E., & Henningfield, J. E. (1984). Abuse liability assessment in human subjects. Trends in Pharmacological Sciences, 5, 196–200.
Johnson, B. A., Roache, J. D., Javors, M. A., DiClemente, C. C., Cloninger, C. R., Prihoda, T. J.et al, . (2000). Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial. Journal of the American Medical Association, 284(8), 963–971.
Johnston, L. D., O’Malley, P. M., & Bachman, J. G. (2003). Monitoring the future national survey results on drug use, 1975–2002. National Institute on Drug Abuse, 1, 386–391.
Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenbert, J. E. (2007). The Monitoring the Future Study. Retrieved December 15, 2007, from http://www.monitoringthefuturestudy.org/data.
Jones, H. E., & Griffiths, R. R. (2003). Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers. Psychopharmacology, 165, 280–290.
Julien, R. M. (2001). A primer of drug action, 9th ed. New York: Worth Publishers.
Kalivas, P. W., Sorg, B. A., & Hooks, M. S. (1993). The pharmacology and neural circuitry of sensitization to psychostimulants. Behavioral Pharmacology, 4, 315–334.
Kandel, D. B., & Chen, K. (2000). Extent of smoking and nicotine dependence in the United States: 1991–1993. Nicotine and Tobacco Research, 2(3), 263–274.
Kandel, D. B., Schaffran, C., Griesler, P., Samuolis, J., Davies, M., & Galanti, R. (2005). On the measurement of nicotine dependence in adolescence: Comparisons of the mFTQ and a DSM-IV-based scale. Journal of Pediatric Psychology, 30(4), 319–332.
Kandel, D. B., Wu, P., & Davies, M. (1994). Maternal smoking during pregnancy and smoking by adolescent daughters. American Journal of Public Health, 84(9), 1407–1413.
Kelly, T. H., Foltin, R. W., & Fischman, M. W. (1991). Effects of repeated amphetamine exposure on multiple measures of human behavior. Pharmacology Biochemistry & Behavior, 38, 417–426.
Kelly, T. H., Robbins, G., Martin, C. A., Fillmore, M. T., Lane, S. D., Harrington, N. G.et al, . (2006). Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status. Psychopharmacology (Berl), 189(1), 17–25.
Kessler, D. A., Natanblut, S. L., Wilkenfeld, J. P., Lorraine, C. C., Mayl, S. L., Bernstien, I. B. G.et al, . (1997). Nicotine addiction: A pediatric disease. Journal of Pediatrics, 130(4), 518–524.
Klein, R. G., Abikoff, H., Klass, E., Ganeles, D., Seese, L. M., & Pollack, S. (1997). Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Archives of General Psychiatry, 54(12), 1073–1080.
Klein-Schwartz, W. (2002). Abuse and toxicity of methylphenidate. Current Opinion in Pediatrics, 14, 219–223.
Knutti, R., Rothweiler, H., & Schlatter, C. (1982). The effect of pregnancy on the pharmacokinetics of caffeine. Archives of Toxicology Supplement, 5, 187–192.
Kopstein, A. (2001). Tobacco use in America: Findings from the 1999 National Household Survey on drug abuse. (Analytic series: A-15, DHHS Publication N. SMA 02-3622). Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies.
Kota, D., & Martin, B. R. (2007). Nicotine dependence and reward differ between adolescent and adult male mice. The Journal of Pharmacology and Experimental Therapeutics, 322(1), 399–401.
Krasnegor, N. A., Gray, D. B., & Thompson, T. (1986). Advances in behavioral pharmacology, Vol. 5: Developmental behavioral pharmacology. Hillsdale, NJ: Lawrence Erlbaum Associates.
Kreek, M. J., & Koob, G. F. (1998). Drug dependence: Stress and dysregulation of reward pathways. Drug and Dependence, 51, 23–47.
Kuczenski, R., & Segal, D. S. (2001). Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: Relative roles of dopamine and norepinephrine. The Journal of Pharmacology and Experimental Therapeutics, 296, 876–883.
Kuczenski, R., & Segal, D. S. (2002, August 15). Exposure of adolescent rats to oral methylphenidate: Preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. Journal of Neuroscience, 22(16), 7264–7271.
Lambert, N. M., & Hartsough, C. S. (1998). Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. Journal of Learning Disabilities, 31(6), 533–544.
Law, K. L., Stroud, L. R., LaGasse, L. L., Niaura, R., Liu, J., & Lester, B. M. (2003). Smoking during pregnancy and newborn neurobehavior. Pediatrics, 111(6 Pt. 1), 1318–1323.
Leon, M. R. (2000). Effects of caffeine on cognitive, psychomotor, and affective performance of children with attention-deficit/hyperactivity disorder. Journal of Attention Disorders, 4, 27–47.
Lesch, K. P. (2005). Alcohol dependence and gene x environment interaction in emotion regulation: Is serotonin the link? European Journal of Pharmacology, 526(1–3), 113–124.
Levin, E. D., Rezvani, A. H., Montoya, D., Rose, J. E., & Swartzwelder, H. S. (2003). Adolescent-onset nicotine self-administration modeled in female rats. Psychopharmacology, 169(2), 141–149.
Leviton, A. (1992). Behavioral correlates of caffeine consumption by children. Clinical Pediatrics, 31(12), 742–750.
Leviton, A., & Cowan, L. (2002). A review of the literature relating caffeine consumption by women to their risk of reproductive hazards. Food & Chemical Toxicology, 40(9), 1271–1310.
Liu, X., Koren, A. O., Yee, S. K., Pechnick, R. N., Poland, R. E., & London, E. D. (2003). Self-administration of 5-iodo-A-85380, a beta-2 selective nicotinic receptor ligand by operantly trained rats. Neuroreports, 14, 1503–1505.
Malinauskas, B. M., Aeby, V. G., Overton, R. F., Carpenter-Aeby, T., & Barber-Heidal, K. (2007, October 31). A survey of energy drink consumption patterns among college students. Nutrition Journal, 6, 35.
Martin, C. A., Guenther, G., Bingcang, C., Rayens, M. K., & Kelly, T. H. (2007). Measurement of the subjective effects of methylphenidate in 11-to-15 year old children with the attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 17(1), 63–73.
Martin, C. A., Kelly, T. H., Rayens, M. K., Brogli, B., Himelreich, K., Brenzel, A.et al, . (2004). Sensation seeking and symptoms of disruptive disorder: Association with nicotine, alcohol and marijuana use in early-and mid-adolescents. Psychological Reports, 94(3 Pt. 1), 75–82.
Martin, W. R., Sloan, J. W., Sapira, J. D., & Jasinski, D. R. (1971). Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clinical Pharmacology and Therapeutics, 12, 245–258.
Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J. P.et al, . (2005). Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature, 436, 103–107.
McCabe, S. E., Teter, C. J., & Boyd, C. J. (2004a). The use, misuse and diversion of prescription stimulants among middle and high school students. Substance Use & Misuse, 39(7), 1095–1116.
McCabe, S. E., Teter, C. J., & Boyd, C. J. (2006a). Medical use, illicit use and diversion of prescription stimulant medication. Journal of Psychoactive Drugs, 38(1), 43–56.
McCabe, S. E., Teter, C. J., & Boyd, C. J. (2006b). Medical use, illicit use and diversion of abusable prescription drugs. Journal of American College Health, 54(5), 269–278.
McCabe, S. E., Teter, C. J., Boyd, C. J., & Guthrie, S. K. (2004b). Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001. Journal of Adolescent Health, 35(6), 501–504.
Milberger, S., Biederman, J., Faraone, S. V., Chen, L., & Jones, J. (1997). ADHD is associated with early initiation of cigarette smoking in children and adolescents. Journal of the American Academy Child & Adolescent Psychiatry, 36(1), 37–44.
Mokdad, A. H., Marks, J. S., Stroup, D. F., & Gerberding, J. L. (2004). Actual causes of death in the United States, 2000. The Journal of the American Medical Association, 291(10), 1238–1245.
Moll, G. H., Hause, S., Ruether, E., Rothenberger, A., & Huether, G. (2001). Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. Journal of Child and Adolescent Psychopharmacology, 11(1), 15–24.
Morgan, K. J., Stults, V. J., & Zabik, M. E. (1982). Amount and dietary sources of caffeine and saccharin intake by individuals ages 5 to 18 years. Regulatory Toxicology and Pharmacology, 2(4), 296–307.
Muneoka, K., Ogawa, T., Kamei, K., Mimura, Y., Kato, H., & Takigawa, M. (2001). Nicotine exposure during pregnancy is a factor which influences serotonin transporter density in the rat brain. European Journal of Pharmacology, 411(3), 279–282.
Myllynen, P., Pasanen, M., & Pelkonen, O. (2005). Human placenta: A human organ for developmental toxicology research and biomonitoring. Placenta, 26(5), 361–371.
Nasello, A. G., & Ramirez, O. A. (1978a). Open field and Lashley III maze behavior of the offspring of amphetamine treated rats. Psychopharmacology, 58, 171–173.
Nasello, A. G., & Ramirez, O. A. (1978b). Brain catecholamines metabolism in the offspring of amphetamine treated rats. Pharmacology, Biochemistry and Behavior, 9, 17–20.
Nasello, A. G., Astrada, A. C., & Ramirez, O. A. (1974). Effects on the acquisition of conditioned avoidance responses and seizure threshold in the offspring of amphetamine treated gravid rats. Psychopharmacology, 40, 25–31.
Nasif, F. J., Cuadra, G. R., & Ramirez, O. A. (1999). Permanent alteration of central noradrenergic system by prenatally administered amphetamine. Developmental Brain Research, 112, 181–188.
National Highway Traffic Safety Administration (NHTSA). (2003). Traffic Safety Facts 2002: Alcohol (DOT Publication No. HS-809–606). Washington, DC: NHTSA, National Center for Statistics & Analysis. Retrieved March 27, 2008, from http://www-nrd.nhtsa.dot.gov/pdf/nrd-30/NCSA/TSF2002/2002alcfacts.pdf.
National Institute on Alcohol Abuse and Alcoholism (NIAAA) (2004–2005). Alcohol and development in youth – A multidisciplinary overview. Alcohol Research & Health, 28(3).
Nichter, M., Nichter, M., Thompson, P. J., Shiffman, S., & Moscicki, A. B. (2002). Using qualitative research to inform survey development on nicotine dependence among adolescents. Drug and Alcohol Dependence, 68(Suppl. 1), S41–S56.
Okoli, C. T. C., Kelly, T. H., & Hahn, E. L. (2007). Secondhand smoke and nicotine exposure: A brief review. Addictive Behaviors, 32, 1977–1988.
O’Loughlin, J., DiFranza, J., Tyndale, R. F., Meshefedjian, G., McMillan-Davey, E., Clarke, P. B. et al (2003). Nicotine-dependence symptoms are associated with smoking frequency in adolescents. American Journal of Preventive Medicine, 25(3), 219–225.
Orbeta, R. L., Overpeck, M. D., Ramcharran, D., Kogan, M. D., & Ledsky, R. (2006). High caffeine intake in adolescents: Associations with difficulty sleeping and feeling tired in the morning. Journal of Adolescent Health, 38, 451–453.
Ostrea, E. M., Mantaring, J. B., III, & Silvestre, M. A. (2004). Drugs that affect the fetus and newborn infant via the placenta or breast milk. Pediatric Clinics of North America, 51, 539–579.
Parsons, W. D., & Neims, A. H. (1981). Prolonged half-life of caffeine in healthy tem newborn infants. Journal of Pediatrics, 98(4), 640–641.
Picciotto, M. R., & Corrigall, W. A. (2002). Neuronal systems underlying behaviors related to nicotine addiction: Neural circuits and molecular genetics. Journal of Neuroscience, 22(9), 3338–3341.
Picciotto, M. R., Zoli, M., & Changeux, J. P. (1999). Use of knock-out mice to determine the molecular basics for the actions of nicotine. Nicotine and Tobacco Research, 1(Suppl. 2), S121–S125.
Pidoplichko, V. I., Noguchi, J., Areola, O. O., Liang, Y., Peterson, J., Zhang, T.et al, . (2004). Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction. Learning and Memory, 11(1), 60–69.
Pirie, P. L., Lando, H., Curry, S. J., McBride, C., & Grothaus, L. C. (2000). Tobacco, alcohol, and caffeine use and cessation in early pregnancy. American Journal of Preventive Medicine, 18(1), 54–61
Pollak, C. P., & Bright, D. (2003). Caffeine consumption and weekly sleep patterns in US seventh-, eighth-, and ninth-graders. Pediatrics, 111, 42–46.
Poulin, C. (2007). From attention-deficit/hyperactivity disorder to medical stimulant use to diversion of prescribed stimulants to non-medical stimulant use: Connecting the dots. Addiction, 102, 740–752.
Ramirez, O. A., & Carrer, H. F. (1983). Noradrenergic modulation of neural transmission in the offspring of amphetamine treated rats. Canadian Journal of Physiology and Pharmacology, 2, 766–769.
Ramirez, O. A., Carrer, H. F., & Nasello, A. G. (1979). Prenatal amphetamine exposure: Ovulation, sexual behavior and hypothalamic monoamine. Pharmacology, Biochemistry and Behavior, 11, 605–609.
Rapoport, J. L., Berg, C. J., Ismond, D. R., Zahn, T. P., & Neims, A. (1984). Behavioral effects of caffeine in children. Relationship between dietary choice and effects of caffeine challenge. Archives of General Psychiatry, 41, 1073–1079.
Rapoport, J. L., Elkins, R., Neims, A., Zahn, T., & Berg, C. J. (1981). Behavioral and autonomic effects of caffeine in normal boys. Developmental Pharmacology and Therapeutics, 3, 74–82.
Rasch, V. (2003). Cigarette, alcohol, and caffeine consumption: Risk factors for spontaneous abortion. Acta Obstetricia et Gynecologica Scandinavica, 82(2), 182–188.
Rayburn, W. F., & Bogenschutz, M. P. (2004). Pharmacotherapy for pregnant women with addictions. American Journal of Obstetrics and Gynecology, 191(6), 1885–1897.
Richardson, S. A., & Tizabi, Y. (1994). Hyperactivity in the offspring of nicotine-treated rats: Role of the mesolimbic and nigrostriatal pathways. Pharmacology, Biochemistry and Behavior, 47(2), 331–337.
Rush, C. R., Higgins, S. T., Vansickel, A. R., Stoops, W. W., Lile, J. A., & Glaser, P. E. (2005). Methlyphenidate increases cigarette smoking. Psychopharmacology (Bel), 181(4), 781–789.
Salminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. X.et al, . (2004). Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Molecular Pharmacology, 65, 1526–1535.
Savitz, D. A., Chan, R. L., Herring, A. H., Howards, P. P., & Hartmann, K. E. (2008). Caffeine and miscarriage risk. Epidemiology, 19(1), 55–62.
Scheffler, R. M., Hinshaw, S. P., Modrek, S., & Levine, P. (2007). The global market for ADHD medications. Health Affairs, 26(2), 450–457.
Schenk, S. & Izenwasser, S. (2002). Pretreatment with methylphenidate sensitizes rats to the reinforcing effects of cocaine. Pharmacology, Biochemistry and Behavior, 72(3), 651–657.
Schuckit, M. A. & Smith, T. L. (2004). Changes over time in the self-reported level of response to alcohol. Alcohol and Alcoholism, 39(5), 433–438.
Sher, L. (2006). Functional magnetic resonance imaging studies of neurocognitve effects of alcohol use on adolescents and young adults. International Journal of Adolescent Medicine and Health, 18(1), 3–7.
Slotkin, T. A. (2002). Nicotine and the adolescent brain: Insights from an animal model. Neurotoxicology and Teratology, 24(3), 369–384.
Slotkin, T. A., Pinkerton, K. E., Auman, J. T., Qiaio, D., & Seidler, F. J. (2002). Perinatal exposure to environmental tobacco smoke upregulates nicotinic cholinergic receptors in monkey brain. Brain Research, Developmental Brain Research, 133(2), 175–179.
Smith, L. M., LaGasse, L. L., Derauf, C., Grant, P., Shah, R., Arria, A.et al, . (2006). The infant development, environment, and lifestyle study: Effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics, 118(3), 1149–1156.
Sokol, R. J., Delaney-Black, V., Nordstrom, B. (2003). Fetal alcohol syndrome disorder. Journal of the American Medical Association, 290(22), 2996–2999.
Solanto, M. V. (1998). Neuropsychopharmacology mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration. Behavioural Brain Research, 94, 127–152.
Soliman, M. A., Pedersen, J. A., Park, H., Castaneda-Jimenez, A., Stenstrom, M. K., & Suffet, I. H. (2007). Human pharmaceuticals, antioxidants, and plasticizers in wastewater treatment plant and water reclamation plant effluents. Water Environment Research, 79(2), 156–167.
Song, M., Wang, X. Y., Zhao, M., Wang, X. Y., Zhai, H. F., & Lu, L. (2007). Role of stress in acquisition of alcohol-conditioned place preference in adolescent and adult mice. Alcoholism, Clinical and Experimental Research, 31(12), 2001–2005.
Sood, B., Delaney-Black, V., Covington, C., Nordstrom-Klee, B., Ager, J., Templin, T.et al, . (2001). Prenatal alcohol exposure and childhood behavior at age 6 and 7. Pediatrics, 108(2), e34.
Spear, L. P. (2002). The adolescent brain and the college drinker: Biological basis of propensity to use and misuse alcohol. Journal of Studies on Alcohol, (Suppl. 14), 71–81.
Spear, L. P. (2004). Adolescence and the trajectory of alcohol use: Introduction to part VI. Annals of the New York Academy of Sciences, 1021, 202–205.
Spear, N. E., & Molina, J. C. (2005). Fetal or infantile exposure to ethanol promotes ethanol ingestion in adolescence and adulthood: A theoretical review. Alcoholism, Clinical and Experimental Research, 29(6), 909–929.
Stein, M. A., Krasowski, M., Leventhal, B. L., Phillips, W., & Bender, B. G. (1996). Behavioral and cognitive effects of methylxanthines. A meta-analysis of theophylline and caffeine. Archives of Pediatric and Adolescent Medicine, 150, 284–288.
Stoops, W. W., Lile, J. A., Robbins, C. G., Martin, C. A., Rush, C. R., & Kelly, T. H. (2007). The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: Influence of sensation-seeking status. Addictive Behaviors, 32(6), 1177–1188.
Story, M., & Neumark-Sztainer, D. (1998). Diet and adolescent behavior: Is there a relationship. Adolescent Medicine, 9, 283–298.
Sussman, S., Pentz, M.A., Spruijt-Metz, D., & Miller, T. (2006, June 9). Misuse of “study drugs”: Prevalence, consequences, and implications for policy. Substance Abuse Treatment, Prevention and Policy, 1, 15.
Swanson, J. M., Gupta, S., Williams, L., Agler, D., Lerner, M., & Wigal, S. (2002a). Efficacy of a new pattern of methylphenidate for the treatment of ADHD: Effects on activity level in the classroom and on the playground. Journal of the American Academy of Child and Adolescent Psychiatry, 41(11), 1306–1314.
Swanson, J. M., Lerner, M., Wigal, T., Steinhoff, K., Greenhill, L., Posner, K.et al, . (2002b). The use of a laboratory school protocol to evaluate concepts about efficacy and side effects of new formulations of stimulant medications. Journal of Attention Disorders, 6(Suppl. 1), S73–S88.
Swartzwelder, H. S., Wilson, W. A., & Tayyeb, M. I. (1995). Age-dependent inhibition of long-term potentiation by ethanol in immature versus mature hippocampus. Alcoholism, Clinical and Experimental Research, 19(6), 1480–1485.
Tapper, A. E., McKinney, S. L., Nashmi, R., Schwarz, J., Deshpande, P., Labarca, C.et al, . (2004). Nicotine activation of alpha4* receptors: Sufficient for reward, tolerance, and sensitization. Science, 306, 1029–1032.
Tennant, F. S., & Detels, R. (1976). Relationship of alcohol, cigarette, and drug abuse in adulthood with alcohol, cigarette and coffee consumption in childhood. Preventive Medicine, 5, 70–77.
Toro, R., Leonard, G., Lerner, J. V., Lerner, R. M., Perron, M., Pike, G. B.et al (2008). Prenatal exposure to maternal cigarette smoking and the adolescent cerebral cortex. Neuropsychopharmacology, 33(5), 1019–1027.
Torres-Reveron, A. & Dow-Edwards, D. L. (2005). Repeated administration of methylphenidate in young, adolescent and mature rat affects the response to cocaine later in adulthood. Psychopharmacology (Berl), 181(1), 38–47.
Trauth, J. A., McCook, E. C., Seidler, F. J., & Slotkin, T. A. (2000a). Modeling adolescent nicotine exposure: Effects on cholinergic systems in rat brain regions. Brain Research, 873, 18–25.
Trauth, J. A., Seidler, F. J., & Slotkin, T. A. (2000b). Persistent and delayed behavioral changes after nicotine treatment in adolescent rats. Brain Research, 880(1–2), 167–172.
Tsai, G. E., Ragan, P., Chang, R., Chen, S., Linnoila, M. I., & Coyle, J. T. (1998). Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal. American Journal of Psychiatry, 155(6), 726–732.
Upadhyaya, H. P., Deas, D., & Brady, K. (2005a). A practical clinic approach to the treatment of nicotine dependence in adolescents. Clinical Perspectives, 44(9), 942–946.
Upadhyaya, H. P., Deas, D., Brady, K. T., & Kruesi, M. (2002). Cigarette smoking and psychiatric comorbidity in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 41(11), 1294–1305.
Upadhyaya, H. P., Rose, K., Wang, W., O’Rourke, K., Sullivan, B., Deas, D.et al, . (2005b). Attention-deficit/hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults. Journal of Child and Adolescent Psychopharmacology, 15(5), 799–809.
Valek, M., Laslavić, B., & Laslavić, Z. (2004). Daily caffeine intake among Osijek high school students: Questionnaire study. Croatian Medical Journal, 45, 72–75.
Valvassori, S. S., Frey, B. N., Martins, M. R., Reus, G. Z., Schimidtz, F., Inacio, C. G.et al, . (2007). Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats. Behavioral Pharmacology, 18, 205–212.
Verheul, R., van den Brink, W., & Geerlings, P. (1999). A three-pathway psychobiological model of craving for alcohol. Alcohol and Alcoholism, 34(2), 197–222.
Vermeiren, R., Schwab-Stone, M., Deboutte, D., Leckman, P. E., & Ruchkin, V. (2003). Violence exposure and substance use in adolescents: Findings from three countries. Pediatrics, 111, 535–540.
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Gerasimov, M., Maynard, L.et al, . (2001). Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. The Journal of Neuroscience, 21, RC121.
Wafford, K. A., Burnett, D., Harris, R. A., & Whiting, P. J. (1993). GABAA receptor subunit expression and sensitivity to ethanol. Alcohol and Alcoholismt, (Suppl. 2), 327–330.
Wagner, F. A. & Anthony, J. C. (2002). From first drug use to drug dependence: Developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology, 26(4), 479–488.
Wakschlag, L. S., Leventhal, B. L., Pine, D. S., Pickett, K. E., & Carter, A. S. (2006). Elucidating early mechanisms of developmental psychopathology: The case of prenatal smoking and disruptive behavior. Child Development, 77(4), 893–906.
Walsh, R. A., Redman, S., & Adamson, L. (1996). The accuracy of self-report of smoking status in pregnant women. Addictive Behaviors, 21(5), 675–679.
Weinberg, B. A. & Bealer, B. K. (2001). The world of caffeine. New York: Routledge.
Westover, A. N., McBride, S., & Haley, R. W. (2007). Stroke in young adults who abuse amphetamines or cocaine. Archives of General Psychiatry, 64(April), 495–502.
Wilens, T. E., Biederman, J., Mick, E., Faraone, S. V., & Spencer, T. (1997). Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. Journal of Nervous and Mental Disease, 185(8), 475–482.
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003). Does stimulant therapy of attention-deficit hyperactivity disorder beget later substance abuse? A meta-analytic review of literature. Pediatrics, 111(1), 179–185.
Wilens, T. E., Gignac, M., Swezey, A., Monuteaux, M. C., & Biederman, J. (2006). Characteristics of adolescents and young adults with ADHD who divert or misuses their prescribed medications. Journal of the American Academy of Child & Adolescent Psychiatry, 45(4), 408–414.
Wolraich, M. L., & Doffing, M. A. (2004). Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate. CNS Drugs, 18(4), 243–250.
Xu, Z., Seidler, F. J., Ali, S. F., Slikker, W., & Slotkin, T. A. (2001). Fetal and adolescent nicotine administration: Effects on CNS serotonergic systems. Brain Research, 914, 166–178.
Yang, P.B., Swann, A.C., & Dafny, N. (2003, October 17). Chronic pretreatment with methylphenidate induces cross-sensitization with amphetamine. Life Sciences, 73(22), 2899–2891.
Zhang, T. A., Maldve, R. E., & Morrisett, R. A. (2006). Coincident signaling in mesolimbic structures underlying alcohol reinforcement. Biochemical Pharmacology, 72(8), 919–927.
Zito, J. M., Safer, D. J., dosReis, S., Magder, L. S., Gardner, J. F., & Zarin, D. A. (1999). Psychotherapeutic medication patterns for youths with attention-deficit hyperactivity disorder. Archives of Pediatric and Adolescent Medicine, 153(12), 1257–1263.
Zuvekas, S. H., Vitiello, B., & Norquist, G. S. (2006). Recent trends in stimulant medication use among U.S. children. The American Journal of Psychiatry, 163(4), 579–585.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Kelly, T., Kazura, A., Lommel, K., Babalonis, S., Martin, C. (2009). A Biological/Genetic Perspective: The Addicted Brain . In: Leukefeld, C., Gullotta, T., Staton-Tindall, M. (eds) Adolescent Substance Abuse. Issue in Children’s and Families’ Lives, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-09732-9_2
Download citation
DOI: https://doi.org/10.1007/978-0-387-09732-9_2
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-09730-5
Online ISBN: 978-0-387-09732-9
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)